Table 1.
Characteristics of patients initiating hepatitis C virus infection treatment in an urban primary care clinic by drug use and drug treatment status.
| Characteristic | Total N = 89 (%) |
No active drug use
|
Active drug use
|
|||||
|---|---|---|---|---|---|---|---|---|
| No OAT N = 43 |
OAT N = 15 |
Pa | No OAT N = 10 |
Pa | OAT N = 21 |
Pa | ||
| Age (median, IQR) | 59 (54,64) | 63 (56,68) | 58 (54,66) | 0.29 | 55 (53,58) | 0.02 | 56 (52,59) | 0.001 |
| Sex, male | 56 (63) | 20 (47) | 9 (60) | 0.55 | 9 (90) | 0.02 | 18 (86) | 0.002 |
| Race/ethnicity | ||||||||
| Black | 35 (39) | 22 (51) | 5 (33) | 0.08 | 3 (30) | 0.23 | 5 (24) | 0.08 |
| Hispanic/latino | 48 (54) | 20 (47) | 7 (47) | 6 (60) | 15 (71) | |||
| White/other | 6 (7) | 1 (2) | 3 (20) | 1 (10) | 1 (5) | |||
| HIV infection, yes | 21 (24) | 8 (19) | 4(27) | 0.49 | 5(50) | 0.05 | 4 (19) | 1 |
| Cirrhosis, yes | 31 (35) | 14 (33) | 7(47) | 0.36 | 3 (30) | 1 | 7 (33) | 1 |
| Genotype 1 | 84 (94) | 42 (98) | 14 (93) | 0.45 | 9 (90) | 0.35 | 19 (91) | 0.25 |
| Previous treatment | 19 (21) | 12 (28) | 2 (13) | 0.32 | 1 (10) | 0.42 | 4 (19) | 0.55 |
| Psychiatric illness | 43 (48) | 11 (26) | 10 (67) | 0.01 | 7 (70) | 0.02 | 15 (71) | 0.001 |
| Alcohol use, yes | 22 (25) | 11 (26) | 1 (7) | 0.16 | 4 (40) | 0.44 | 6 (29) | 1 |
| History of injection drug use | 56 (63) | 21 (49) | 13 (87) | 0.01 | 6 (60) | 0.39 | 16 (76) | 0.03 |
| Opiate use | 19 (21) | – | – | 3 (30) | 16 (76) | |||
| Cocaine use | 10 (11) | – | – | 3 (30) | 7 (33) | |||
| Marijuana use | 12 (14) | – | – | 7 (70) | 5 (24) | |||
| Amphetamine use | 1 (1) | – | – | 0 (0) | 1 (5) | |||
a
P values calculated using chi-square or Fisher exact tests, as appropriate, compared to the “no active drug use, no OAT” group (non-PWUD).